<p>β-hexosaminidase release was assayed from BMMCs as it is as an index of mast cell degranulation (n = 5). BMMCs were (5 × 10<sup>4</sup>cells/well) incubated with GMF (100 ng/ml), MPP+ (10 μM), α-synuclein (5 μg/ml) or IL-33 (50 ng/ml) for 30 min at 37°C and the β-hexosaminidase release was measured in the supernatant media as well as in the cell lysates. Absorbance was measured at 405 nm in an ELISA plate reader. The results were expressed as % release. P<0.05 compared to un-treated control cells. *p<0.05 control vs treated, ANOVA and Tukey-Kramer/Unpaired t test.</p
<p>(A) RBL-2H3 cells were stably transfected with SNAP29-GFP, SNAP23-GFP or GFP. Homogenates for eac...
<p>(A) FcεRI-mediated β-hexosaminidase release. Control or PI3K-C2α-knockdown cells were sensitized ...
<p>(A–C) FcγRII<sup>−/−</sup> or WT B6 mBMMCs were pre-incubated with or without IL-33 (10 ng/ml) fo...
<p>LAD2 mast cells were stimulated with mannitol (5%, 10%, and 17%) for 30 minutes, and β-hexosamini...
<p>Human mast cells were incubated with GMF (100 ng/ml), IL-33 (50 ng/ml), α-synuclein (5 μg/ml) and...
<p>(A) LAD2 mast cells and (B) hCBMCs were stimulated with NT for 30 min at 37°C. SP was used as a “...
<p>β-hexosaminidase is expressed as percentage of total β-hexosaminidase in the cells. Data is prese...
<p>(A) Granule release of wild type and p110γ<sup>−/−</sup> BMMCs was determined detecting β-hexosam...
<p>Mast cells were transfected with miR-223 inhibitor (miR-223 inhibitor group) or its control (cont...
<p>Mouse mast cells were incubated with GMF or IL-33, both at 50 ng/ml for 48 h in vitro (n = 4). Af...
<p>Release of β-hexosaminidase from peritoneal cells (2×10<sup>6</sup>) was measured following 15 mi...
<p>Bone marrow-derived mast cells (BMMCs) were isolated from 23 inbred and recombinant inbred (BxD) ...
<p>(A) Cells were pre-treated with Blt-2 (50 μM) 30 min prior to AgNP (50 μg/ml) exposure for 1 h an...
<p>A. IL-4/IgE treated and non-treated HUCBMCs were incubated with A23187 (60 nM) plus PMA (100 ng/m...
<p>Degranulation was determined by staining with dyes and measuring the release of histamine and try...
<p>(A) RBL-2H3 cells were stably transfected with SNAP29-GFP, SNAP23-GFP or GFP. Homogenates for eac...
<p>(A) FcεRI-mediated β-hexosaminidase release. Control or PI3K-C2α-knockdown cells were sensitized ...
<p>(A–C) FcγRII<sup>−/−</sup> or WT B6 mBMMCs were pre-incubated with or without IL-33 (10 ng/ml) fo...
<p>LAD2 mast cells were stimulated with mannitol (5%, 10%, and 17%) for 30 minutes, and β-hexosamini...
<p>Human mast cells were incubated with GMF (100 ng/ml), IL-33 (50 ng/ml), α-synuclein (5 μg/ml) and...
<p>(A) LAD2 mast cells and (B) hCBMCs were stimulated with NT for 30 min at 37°C. SP was used as a “...
<p>β-hexosaminidase is expressed as percentage of total β-hexosaminidase in the cells. Data is prese...
<p>(A) Granule release of wild type and p110γ<sup>−/−</sup> BMMCs was determined detecting β-hexosam...
<p>Mast cells were transfected with miR-223 inhibitor (miR-223 inhibitor group) or its control (cont...
<p>Mouse mast cells were incubated with GMF or IL-33, both at 50 ng/ml for 48 h in vitro (n = 4). Af...
<p>Release of β-hexosaminidase from peritoneal cells (2×10<sup>6</sup>) was measured following 15 mi...
<p>Bone marrow-derived mast cells (BMMCs) were isolated from 23 inbred and recombinant inbred (BxD) ...
<p>(A) Cells were pre-treated with Blt-2 (50 μM) 30 min prior to AgNP (50 μg/ml) exposure for 1 h an...
<p>A. IL-4/IgE treated and non-treated HUCBMCs were incubated with A23187 (60 nM) plus PMA (100 ng/m...
<p>Degranulation was determined by staining with dyes and measuring the release of histamine and try...
<p>(A) RBL-2H3 cells were stably transfected with SNAP29-GFP, SNAP23-GFP or GFP. Homogenates for eac...
<p>(A) FcεRI-mediated β-hexosaminidase release. Control or PI3K-C2α-knockdown cells were sensitized ...
<p>(A–C) FcγRII<sup>−/−</sup> or WT B6 mBMMCs were pre-incubated with or without IL-33 (10 ng/ml) fo...